Stockpolly
Search
MDWD · NASDAQ · Biotechnology

MediWound (MDWD)

Clears burn eschar and chronic wounds with enzymatic technology instead of surgery.

$13.08
At close+0.46 (+3.65%)
Watchlist

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue555546465213
Cost of revenue454545345213
Gross profit111011111000
4545676778810
Research & development221233333456
333334344344
Selling & marketing101110112−110
General & administrative102224222420
Other expenses000000000000
Operating income−3−4−4−4−5−6−5−6−7−8−8−9
12−6−2−525−84152
Interest income120102504103
Interest expense006250080001
Other non-operating income0−90−1010−50−4−2−50
Income before tax−2−2−10−6−10−4−1−13−3−7−3−7
Income tax expense000000000000
Net income from continuing operations−2−2−10−6−10−4−1−13−3−7−3−7
Net income−2−2−10−6−10−4−1−13−3−7−3−7
EPS, basic−$0.24−$0.19−$1.05−$0.68−$0.98−$0.36−$0.07−$1.23−$0.24−$0.56−$0.23−$0.57
EPS, diluted−$0.24−$0.19−$1.05−$0.68−$0.98−$0.36−$0.07−$1.23−$0.24−$0.56−$0.23−$0.57
Weighted average shares, basic99991111101111131313
Weighted average shares, diluted99991111111111131313
EBITDA−36−3−4−5−160−5−2−5−3−9
Depreciation & amortization000000000100
EBIT−35−4−4−5−16−1−5−3−6−3−9